Authors: Lallemand-Breitenbach, V Zhu, J Puvion, F Koken, M Honore, N Doubeikovsky, A Duprez, E Pandolfi, PP Puvion, E Freemont, P de The, H

Citation: V. Lallemand-breitenbach et al., Role of promyelocytic leukemia (PML) sumolation in nuclear body formation,11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation, J EXP MED, 193(12), 2001, pp. 1361-1371

Authors: Duprez, E Benoit, G Flexor, M Lillehaug, JR Lanotte, M

Citation: E. Duprez et al., A mutated PML/RARA found in the retinoid maturation resistant NB4 subclone, NB4-R2, blocks RARA and wild-type PML/RARA transcriptional activities, LEUKEMIA, 14(2), 2000, pp. 255-261

Authors: Bardos, JI Saurin, AJ Tissot, C Duprez, E Freemont, PS

Citation: Ji. Bardos et al., HPC3 is a new human polycomb orthologue that interacts and associates withRING1 and Bmi1 and Has transcriptional repression properties, J BIOL CHEM, 275(37), 2000, pp. 28785-28792

Authors: Tong, JH Duprez, E Lanotte, M

Citation: Jh. Tong et al., JEM-1, a novel nuclear co-factor: localisation and functional interaction with AP-1, LEUKEMIA, 13(12), 1999, pp. 1982-1992

Authors: Duprez, E Saurin, AJ Desterro, JM Lallemand-Breitenbach, V Howe, K Boddy, MN Solomon, E de The, H Hay, RT Freemont, PS

Citation: E. Duprez et al., SUMO-1 modification of the acute promyelocytic leukaemia protein PML: implications for nuclear localisation, J CELL SCI, 112(3), 1999, pp. 381-393

Authors: Allford, S Grimwade, D Langabeer, S Duprez, E Saurin, A Chatters, S Walker, H Roberts, P Rogers, J Bain, B Patterson, K McKernan, A Freemont, P Solomon, E Burnett, A Goldstone, A Linch, D

Citation: S. Allford et al., Identification of the t(15;17) in AML FAB types other than M3: evaluation of the role of molecular screening for the PML/RAR alpha rearrangement in newly diagnosed AML, BR J HAEM, 105(1), 1999, pp. 198-207